41 related articles for article (PubMed ID: 8578615)
21. Interleukin-3, -5, and granulocyte macrophage colony-stimulating factor-induced adhesion molecule expression on eosinophils by p38 mitogen-activated protein kinase and nuclear factor-[kappa] B.
Wong CK; Ip WK; Lam CW
Am J Respir Cell Mol Biol; 2003 Jul; 29(1):133-47. PubMed ID: 12600815
[TBL] [Abstract][Full Text] [Related]
22. The eosinophil in gut inflammation: effector or director?
Levy AM; Kita K
Gastroenterology; 1996 Mar; 110(3):952-4. PubMed ID: 8608909
[No Abstract] [Full Text] [Related]
23. Contribution of CD54 to human eosinophil and neutrophil superoxide production.
Takashi S; Okubo Y; Horie S
J Appl Physiol (1985); 2001 Aug; 91(2):613-22. PubMed ID: 11457772
[TBL] [Abstract][Full Text] [Related]
24. Conjunctival fibroblasts enhance the survival and functional activity of peripheral blood eosinophils in vitro.
Solomon A; Shmilowich R; Shasha D; Frucht-Pery J; Pe'er J; Bonini S; Levi-Schaffer F
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1038-44. PubMed ID: 10752939
[TBL] [Abstract][Full Text] [Related]
25. Fluvastatin and lovastatin inhibit granulocyte macrophage-colony stimulating factor-stimulated human eosinophil adhesion to inter-cellular adhesion molecule-1 under flow conditions.
Robinson AJ; Kashanin D; O'Dowd F; Fitzgerald K; Williams V; Walsh GM
Clin Exp Allergy; 2009 Dec; 39(12):1866-74. PubMed ID: 19689459
[TBL] [Abstract][Full Text] [Related]
26. Eosinophil apoptosis--pathophysiologic and therapeutic implications.
Simon HU
Allergy; 2000 Oct; 55(10):910-5. PubMed ID: 11030370
[No Abstract] [Full Text] [Related]
27. Anti-allergic therapies: effects on eosinophil progenitors.
Baatjes AJ; Sehmi R; Saito H; Cyr MM; Dorman SC; Inman MD; O'Byrne PM; Denburg JA
Pharmacol Ther; 2002 Jul; 95(1):63-72. PubMed ID: 12163128
[TBL] [Abstract][Full Text] [Related]
28. [The roles of adhesion molecules, cytokines, and chemokines in eosinophil activation during allergic inflammation].
Chihara J
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():116-20. PubMed ID: 9216199
[TBL] [Abstract][Full Text] [Related]
29. Eosinophil apoptosis as a therapeutic target in allergic asthma.
Ilmarinen P; Kankaanranta H
Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):109-17. PubMed ID: 24148899
[TBL] [Abstract][Full Text] [Related]
30. Early activation or "priming" of eosinophils in asthma.
Bruijnzeel PL; Rihs S; Virchow JC; Warringa RA; Moser R; Walker C
Schweiz Med Wochenschr; 1992 Feb; 122(9):298-301. PubMed ID: 1546279
[TBL] [Abstract][Full Text] [Related]
31. H1 antagonists and inhibitors of eosinophil accumulation.
De Vos C
Clin Exp Allergy; 1991 Jan; 21 Suppl 1():277-81. PubMed ID: 1674438
[No Abstract] [Full Text] [Related]
32. Modulation of eosinophil effector functions: the potential role of monoclonal antibodies and chemokine receptor antagonists.
Elsner J; Kapp A
Allergy Asthma Proc; 2000; 21(6):345-9. PubMed ID: 11191099
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms and pharmacological manipulation of eosinophil accumulation in vivo.
Teixeira MM; Williams TJ; Hellewell PG
Trends Pharmacol Sci; 1995 Dec; 16(12):418-23. PubMed ID: 8578615
[TBL] [Abstract][Full Text] [Related]
34. Eosinophil priming by cytokines: from cellular signal to in vivo modulation.
Koenderman L; van der Bruggen T; Schweizer RC; Warringa RA; Coffer P; Caldenhoven E; Lammers JW; Raaijmakers JA
Eur Respir J Suppl; 1996 Aug; 22():119s-125s. PubMed ID: 8871056
[TBL] [Abstract][Full Text] [Related]
35. [Eosinophil apoptosis and asthma].
Dziedziczko A; Pałgan K
Pol Merkur Lekarski; 2004 Jul; 17(97):73-5. PubMed ID: 15559618
[TBL] [Abstract][Full Text] [Related]
36. [The assessment of Eo-CSF and cytokines as eosinopoietic factor].
Kamei T
Nihon Rinsho; 1993 Mar; 51(3):736-40. PubMed ID: 8492450
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
